Health & Fitness
Health and Fitness
Health and Fitness 
Wed, May 26, 2010
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
[ Wed, May 26th 2010
] - Market Wire
Tue, May 25, 2010
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - WOPRAI
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
[ Tue, May 25th 2010
] - Market Wire
St. Jude Medical iscrive il primo paziente alla sperimentazione clinica FAME II per studiare la?uso della tecnologia a riserva
ST. PAUL, Minn.--([ BUSINESS WIRE ])--St. Jude Medical, Inc. (NYSE : STJ), una societ di portata globale impegnata nello sviluppo di dispositivi medicali, ha annunciato oggi in occasione della riunione EuroPCR la™iscrizione del primo paziente alla sperimentazione FAME II (Intervento coronarico percutaneo guidato dalla riserva di flusso frazionale con trattamento medico ottimale rispetto al solo trattamento medico ottimale in pazienti affetti da arteriopatia coronarica stabile).
Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.